Pasithea Therapeutics Corp.
KTTA
$1.19
-$0.02-1.65%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 22.41% | -0.14% | 23.52% | -39.74% | 4.00% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.99% | -38.52% | 167.75% | -170.89% | 444.26% |
| Change in Net Operating Assets | 5.70% | 43.61% | -164.88% | 1,018.01% | -58.76% |
| Cash from Operations | 22.74% | 6.53% | -10.64% | -47.12% | 23.70% |
| Capital Expenditure | -- | -- | -- | -100.00% | 832.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 98.18% | 0.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 200.00% | -283.57% |
| Cash from Investing | -- | -- | -- | 219.24% | -256.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -1.91% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 100.00% | -2,759.11% |
| Foreign Exchange rate Adjustments | -834.48% | -383.33% | -119.35% | 172.09% | -1,333.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 134.48% | 6.48% | -32.83% | 53.93% | -116.23% |
